An impassioned story of a tragic loss compounded by misinformation and contempt. This commentary could not have been more spot on. Opinion | The Nonsense Over Secondhand Fentanyl Overdoses Must End - nytimes.com/2024/08/04/opi… @acmtmedtox @toxicologist12 @JMPerroneMD
Lewis Nelson
@LNelsonMD
Emergency Medicine, Medical Toxicology, Addiction Medicine. Pain Medicine. The dose makes the poison.
49 Following 2.9K Followers 1.3K Posts
Latest posts 5
Amazing insight from @JMPerroneMD highlighting misconceptions of xylazine risk and the damage caused by stigmatization of substance use. @ASAMorg @acmtmedtox @JLoveMD @RutgersTox @JDOrazioMD #xylazine inquirer.com/opinion/commen…
www.inquirer.com We’re talking about fentanyl and xylazine all wrong Rather than stigmatizing people living with addiction, the most important thing we can do is encourage and support people in their journey to recovery. Even though we like their product, they are still just a business. Trying to convince regulators that bup tablets were not safe but their new strips were so as to prevent generic tablets from staying on the market is anticompetitive.
npr.org/2023/06/02/117…
www.npr.org Addiction drug maker will pay more than $102 million fine for stifling competition Indivior was accused of using illegal strategies to keep generic versions of the opioid-treatment medication Suboxone off the market. The company denies wrongdoing. npr.org/2023/06/02/117…
Agree. In fact, I've generally thought it's great that the precipitated withdrawal from naloxone is so short lived...
Naloxone is short acting. That’s a good thing. Withdrawal will pass quickly.View quoted post on X
When naloxone wears off, we can give more if we need to.
I have been treating opioid overdoses for nearly two decades, and I have never, ever thought we needed a long-acting reversal agent.
What the officers and others experience is real to them. The issue is with the messaging and the reporting. njspotlightnews.org/special-report… @acmtmedtox @toxicologist12 @JMPerroneMD